Fate Therapeutics, Inc.
FATE
$0.9205
-$0.0458-4.74%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.15M | -47.68M | -38.43M | -48.00M | -44.12M |
| Total Depreciation and Amortization | 4.81M | 4.61M | 4.72M | 4.82M | 4.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 21.45M | 10.52M | 5.19M | 9.22M | 6.79M |
| Change in Net Operating Assets | -1.91M | 3.13M | -3.79M | 614.00K | -4.19M |
| Cash from Operations | -27.80M | -29.42M | -32.31M | -33.35M | -36.64M |
| Capital Expenditure | -98.00K | -495.00K | -51.00K | -86.00K | -181.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.91M | 25.96M | -53.32M | 17.40M | 45.53M |
| Cash from Investing | 22.82M | 25.46M | -53.37M | 17.31M | 45.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | -- | 75.49M | -- |
| Repurchase of Common Stock | -- | -- | -666.00K | -- | -180.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.13M | 0.00 | 1.94M | 20.00M | -- |
| Cash from Financing | 3.13M | 0.00 | 1.27M | 95.49M | -180.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.85M | -3.96M | -84.41M | 79.45M | 8.54M |
